Current role
Biotechnology · Healthcare
CEO, Board Member
2024-12-16–present
Abizer Gaslightwala
Board Member
Akari Therapeutics Plc (AKTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.
Get AKTX alertsAbout Abizer Gaslightwala
Abizer Gaslightwala is recorded as Board Member at Akari Therapeutics Plc (AKTX) since December 16, 2024 and CEO at Akari Therapeutics Plc (AKTX). Akari Therapeutics Plc reported in an 8-K filed March 20, 2025 that Abizer Gaslightwala was appointed President and Chief Executive Officer, effective April 21, 2025. Akari Therapeutics Plc reported in an 8-K filed December 18, 2024 that Abizer Gaslightwala was appointed director of the Board, effective December 16, 2024. The proxy statement of Akari Therapeutics Plc reports total compensation of $1,663,603 for Abizer Gaslightwala in fiscal 2025, including a base salary of $331,061. Disclosed compensation is on record for 2 fiscal years. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Samir R. Patel (CEO), Samir R. Patel, M.D. (CEO), Hoyoung Huh (Chairman and Board Member) and 6 others.
“On March 14, 2025, Akari Therapeutics, Plc (the "Company") entered into an Executive Offer of Employment Agreement (as amended by a subsequent Chief Executive Officer Letter Agreement, dated March 18, 2025, the "Employment Agreement") with Mr. Abizer Gaslightwala pursuant to which Mr. Gaslightwala will serve as the President and Chief Executive Officer of the Company, effective on or around April 21, 2025 (the "Start Date").”
“On December 16, 2024, the Board approved the appointment of Abizer Gaslightwala to serve as a director of the Board, effective as of December 16, 2024.”
Affiliation history
-
Current
2024-12-16–present
-
Current
Company network
Leadership on record at Akari Therapeutics Plc
- Samir R. Patel CEO
- Samir R. Patel, M.D. CEO
- Hoyoung Huh Chairman, Board Member
- Kameel Farag CFO
- Samir Patel CFO
- Torsten Hombeck CFO
- James Neal Board Member
- Robert Bazemore Board Member
- Sandip Patel Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akari Therapeutics Plc (AKTX) | President and Chief Executive Officer | $331,061 | $1,663,603 |
| 2024 | Akari Therapeutics Plc (AKTX) | President and Chief Executive Officer | — | — |